BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis planArticle Published on 2022-10-202022-11-16 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory symptom approved BNT162b2 Brazil Care case-control study collected conducted Control COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19-related complication Effectiveness Enrollment Ethics evaluate Evidence Follow-up identify material Mutation Older Patient peer-reviewed performed Pfizer-BioNTech polymerase chain populations positive protocol public health randomized clinical trials Research Ethics Committee reverse transcription RT-PCR SARS-CoV-2 SARS-CoV-2 variants screened seeking Statistical analysis plan Study protocol symptomatic tested vaccination [DOI] 10.1371/journal.pone.0276384 PMC 바로가기
Point-of-care detection of SARS-CoV-2 antigen among symptomatic vs. asymptomatic persons: Testing for COVID-19 vs. infectivityArticle Published on 2022-10-172022-11-15 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 치료기술, [키워드] 95% confidence interval acute respiratory syndrome Ag-RDT Antigen Asymptomatic Buenos Aires Care caused Concordance Contact coronavirus disease Coronavirus-2 COVID-19 COVID-19 patient detect diagnose diagnostic evaluate false-negative hypothetical identify individual Infectious virus Isolation pandemic Participants PCR point-of-care positive public health qRT-PCR rapid antigen testing real-time RT-PCR SARS-CoV-2 SARS-CoV-2 antigen SARS-COV-2 infection SARS-CoV-2 RNA SARS-CoV-2 testing subjects Surveillance symptomatic t -value Testing threshold Transmission utility viral kinetics was obtained [DOI] 10.3389/fpubh.2022.995249 PMC 바로가기
High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine BoosterArticle Published on 2022-10-172022-11-15 Journal: The Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome Against binding antibody booster booster dose Breakthrough infection caused clinical trial coronavirus coronavirus 2 coronavirus disease COVID-19 Efficacy Level Neutralizing neutralizing antibody omicron Protein Receptor-binding domain respiratory responses SARS-CoV-2 SARS-CoV-2 variants subunit Support symptomatic the receptor-binding domain vaccination Vaccine vaccine candidate Vaccines variant variants [DOI] 10.1093/infdis/jiac241 PMC 바로가기
Artificial Intelligence and Deep Learning Assisted Rapid Diagnosis of COVID-19 from Chest Radiographical Images: A SurveyArticle Published on 2022-10-122022-11-15 Journal: Contrast media & molecular imaging [Category] COVID19(2023년), SARS, 치료기술, [키워드] Accuracy acting Analysis applied artificial Asymptomatic Chest Chest CT Community complex COVID-19 COVID-19 pandemic CT scan deep detect Diagnosis domain early stage Effects Elsevier examined intelligence learning machine learning MOST outcome pandemic predict problems provide Rapid Research researcher selected survey symptomatic symptomatic case [DOI] 10.1155/2022/1306664 PMC 바로가기
Gam-COVID-Vac, EpiVacCorona, and CoviVac effectiveness against lung injury during Delta and Omicron variant surges in St. Petersburg, Russia: a test-negative case-control studyArticle Published on 2022-10-102022-11-16 Journal: Respiratory Research [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] 95% confidence interval adjusted age booster case-control study case–control study computer tomography COVID-19 COVID-19 pandemic COVID-19 vaccine Decline Delta Delta VOC effective Effectiveness Efficacy epidemiological estimate Evidence Gam-COVID-Vac Infection involved joint low-dose Lung injury lung parenchyma monitoring new SARS-CoV-2 omicron Patient primary analysis provided Registered remained Research Russia SARS-CoV-2 SARS-COV-2 infection severe disease severe lung injury Sex symptomatic two-dose regimen vaccination Vaccine vaccine effectiveness variant variants of concern VoC Volume with COVID-19 [DOI] 10.1186/s12931-022-02206-3 PMC 바로가기
Extended compartmental model for modeling COVID-19 epidemic in SloveniaArticle Published on 2022-10-082022-11-16 Journal: Scientific Reports [Category] 변종, [키워드] absence age approach Asymptomatic disease changes in compartmental model COVID-19 epidemic COVID-19 situation epidemiological European expected explained Extended flexible groups heterogeneous Intervention limitation mathematical outbreak parameter predict predicted progression public health SEIR Slovenia symptomatic unvaccinated populations vaccination viral variant [DOI] 10.1038/s41598-022-21612-7 PMC 바로가기
Imbalanced Angiogenesis in Pregnancies Complicated by SARS-CoV-2 InfectionArticle Published on 2022-10-072022-11-15 Journal: Viruses [Category] COVID19(2023년), SARS, 바이오마커, [키워드] Admission age angiogenic factors antithrombotic therapy Asymptomatic asymptomatic patient clinically collected COVID-19 cut-off value death diagnosed Diagnosis diagnosis of SARS-CoV-2 dysfunction dysregulation endothelial Endothelial dysfunction evaluate Factors FGR gestation growth factor hospital incidence Infection intensive care management marker mother Neonatal Neonate not significantly different Patient placental placental dysfunction preeclampsia Pregnancy pregnant population pregnant women proportion RAS reported resulting Retrospective analysis SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 positive asymptomatic Serum level severity sFlt-1 Stillbirth stratified Symptom symptomatic symptomatic patient symptoms of COVID-19 turn tyrosine was performed with COVID-19 women [DOI] 10.3390/v14102207 PMC 바로가기
Incidence of COVID-19 and Identification of Possible Risk Factors Associated with COVID-19 in Acute Renal Transplant Recipients in PakistanArticle Published on 2022-10-042022-11-15 Journal: Annals of transplantation [Category] COVID19(2023년), SARS, 진단, [키워드] acquisition age baseline Characteristics Comorbidities Compliance COVID-19 COVID-19 disease Diabetes Mellitus enrolled Factor female gender Follow-up Gender Health status hospital Hospital stay identification identify immunosuppressive therapies incidence increased mortality Infection males management measure Measures overall mortality Patient patients Protective questionnaire raised recipient recipients renal required risk factor Risk factors SARS-COV-2 infection serum creatinine susceptible symptomatic Transplant transplants with COVID-19 [DOI] 10.12659/AOT.937688 PMC 바로가기
COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 PeriodsArticle Published on 2022-10-032022-11-16 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 변종, [키워드] addition age Antigen Asymptomatic booster children clinical symptom Community conducted cough COVID-19 COVID-19 symptom COVID-19 testing cross-sectional Delta Duration Evolution Fever first positive Fisher Health Isolation Latinx less loss of taste median myalgia negative test omicron outcome participant Participants Patient Period population immunity positive positive result positive test result Practitioner proportion public health Rapid remained repeated reported reported symptoms San Francisco SARS-COV-2 infection seeking Site sore throat Symptom symptom onset symptomatic symptomatic participant Symptoms Test tested Testing upper respiratory tract vaccination Vaccine variant Viral variants were used with COVID-19 worsening χ2 test [DOI] 10.1001/jamanetworkopen.2022.35844 PMC 바로가기
Increased Mortality Among Persons With Symptomatic Coronavirus Disease 2019 (COVID-19) During the Period of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.617.2 (Delta Variant) Predominance: Alaska, November 2020-October 2021Article Published on 2022-10-032022-11-16 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 변종, [키워드] Alaska B.1.617.2 B.1.617.2 (Delta) coronavirus 2 coronavirus disease COVID-19 death Delta delta variant higher odd Increased Mortality mortality risk Period Person predominant respiratory risk SARS-CoV-2 symptomatic vaccination virulence [DOI] 10.1093/cid/ciac530 PMC 바로가기